essential to clearly distinguish between configurable and custom systems within a GMP-regulated environment. Each system type demands a tailored approach for compliance with GMP automation requirements.

1. Defining Configurable Systems

Configurable systems are pre-built commercial software applications or platforms designed with built-in flexibility allowing users to adjust settings, workflows, and system parameters to meet specific process needs without changing source code. Examples include Laboratory Information Management Systems (LIMS), Manufacturing Execution Systems (MES), and Electronic Batch Record (EBR) software that offer configurable user roles, process flow adjustments, and report generation using standard features.

• Key characteristics: Vendor-developed, validated base product with controlled configuration options.
• System changes are typically limited to settings, parameters, and script-based automation where allowed.
• Supplier validation is leveraged for the software foundation, reducing customer-side grade of effort.

2. Understanding Custom Systems

In contrast, custom systems are developed internally or by third parties specifically tailored to unique business or process requirements. These systems involve bespoke coding and architecture design, resulting in a fully customized application built from the ground up or through extensive modification of existing components.

• Key characteristics: Full control over design, development, and deployment.
• Validation burden is higher due to lack of supplier-provided validation deliverables.
• Changes require formal change control and significant testing efforts.

Identifying whether a system is configurable or fully custom impacts the entire CSV approach — from risk assessment and supplier evaluation to script testing and overall system release.

Step 1: Scoping and Risk Assessment Under GAMP 5 Principles

Effective validation begins with a comprehensive scoping and risk-based planning process guided by GAMP 5 framework. This step ensures regulatory focus and resource allocation align with system complexity and intended use.

1. Perform User Requirements Specification (URS)

Capture detailed functional and regulatory requirements considering aspects such as electronic records management, data integrity needs, security controls, audit trails, and compliance with applicable regulations like FDA Part 11 and EU GMP Annex 11. For configurable systems, clarify which functionalities will be configured and which will remain standard.

2. Conduct Categorization and Risk Analysis

Classify the system based on the GAMP 5 categories: Category 3 (non-configured), Category 4 (configurable off-the-shelf), and Category 5 (custom build). User risk assessment must evaluate potential impact on product quality, patient safety, and data integrity. Use ICH Q9 principles for risk-based decisions to define validation scope, testing depth, and documentation requirements.

3. Define Supplier and Third-Party Controls

For configurable systems, the validation effort leverages supplier documentation, such as manufacturer’s verification and validation records. Establish explicit agreements addressing supplier audits, software lifecycle management, and patch control. Custom system projects require direct involvement in software development lifecycle (SDLC) documentation, including design specifications and code review reports.

Step 2: Validation Planning and Documentation Framework

Documenting a clear and pragmatic validation plan is critical for controlling the CSV lifecycle and demonstrating compliance to regulatory inspectors from the FDA, EMA, or MHRA.

1. Validation Master Plan (VMP)

Develop and maintain a VMP that describes the overall strategy for both configurable and custom systems. The plan must reference specific regulatory expectations—such as 21 CFR Part 11 for electronic records and EU GMP Annex 11—and outline the integration of CSV activities with overarching GMP systems and quality management systems (QMS).

2. System Description and Functional Specifications

Create or review detailed system design documentation. For configurable systems, document the baseline software version and specify configurable parameters with rationale. For custom systems, include architectural design, module functionality, and software development phases.

3. Risk-Based Validation Protocols

Develop validation protocols including Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). The level of testing for configurable systems focuses on configuration testing, usage scenarios, and security controls. Custom systems require full code validation including unit testing, integration testing, and system testing.

Linking this documentation framework explicitly to FDA guidance on software validation ensures expectations for traceability, reproducibility, and documentation control are met.

Step 3: Execution of Validation and Testing Activities

The practical phase of CSV involves rigorous testing and documentation to confirm the system performs according to specifications and regulatory needs.

1. Installation Qualification (IQ)

• Verify installation of the software and hardware complies with manufacturer specifications.
• Document environment setup, configuration files, version control, and system access controls.

2. Operational Qualification (OQ)

• Test system functions against predefined requirements, focusing on configurable parameters for configurable systems and full function coverage for custom applications.
• Execute security and access control testing, including password policies, user roles, and audit trail functionality, critical for compliance with Part 11 and Annex 11.
• Validate electronic signatures and data integrity mechanisms.

3. Performance Qualification (PQ)

• Confirm the system operates reliably under real-world conditions reflecting actual user interactions and workflows.
• Test integration with other systems, data backup, and disaster recovery processes.

Consistent documentation through test scripts, records of testing results, and deviation reports form the foundation for regulatory inspection readiness. Alignment with PIC/S best practices further ensures international compliance harmonization.

Step 4: Managing Change Control and Continuous Compliance

Post-validation, maintaining system compliance requires robust change management aligned with GMP expectations. Both configurable and custom systems undergo evolution—through vendor patches, configuration changes, or custom development extensions—that may affect validated state.

1. Formal Change Control Process

Define procedures for impact assessment, approval, testing, and documentation of changes. The scope includes software patches, parameter alterations, and functional enhancements. Ensure risk assessments are updated and any re-validation or regression testing is appropriately scoped based on risk and regulatory guidance.

2. Periodic Review and Reassessment

Implement periodic review cycles to evaluate system performance, compliance status, and emerging regulatory requirements. This is essential for data integrity assurance, especially where electronic records and audit trails form a critical part of GMP documentation.

3. Incident Handling and CAPA Integration

Incorporate procedures for logging deviations, incidents, and potential non-conformances related to system operation. Corrective and Preventive Actions (CAPA) must address root causes related to software or configuration issues with appropriate follow-up validation if necessary.

Step 5: Documentation Retention and Inspection Preparedness

Compliance demonstration to agencies such as FDA, EMA, and MHRA requires well-organized, accessible documentation for every phase of the CSV lifecycle with a clear audit trail.

1. Comprehensive Documentation Packages

Maintain traceable documentation ranging from URS, risk assessments, VMP, test protocols, execution records, deviations, and final validation reports. Electronic document management systems (EDMS) that comply with Part 11 and Annex 11 expectations enhance document integrity and retrieval speed.

2. Training and Qualification Records

Ensure personnel operating, configuring, or maintaining computer systems receive formal training documented within the quality system. Training records support regulatory inspections and reinforce compliance culture.

3. Preparation for Regulatory Inspections

Conduct internal audits and mock inspections focused on computer system validation to identify gaps and risks. Understand specific regulatory requirements around data integrity, security controls, and system lifecycle management. Reference EU GMP Volume 4 guidelines and EMA’s focus on Annex 11 compliance as part of readiness activities.

By following the above stepwise approach to computer system validation, pharmaceutical manufacturers and supporting organizations in the US, UK, and EU can develop compliant, risk-based CSV programs tailored to the unique challenges posed by configurable and custom systems in GMP automation.